$MRK

AI Analysis

Generated on May 11, 2026

AI Score
73/ 100
Hold$MRK

Merck & Co. Inc.

$MRKNYSEHealthcareMega-Cap

Merck is a global pharmaceutical company with leading positions in oncology (Keytruda), vaccines, and animal health.

Market Cap
$280.0B
Revenue (TTM)
$64.2B
+7.0%
Net Income (TTM)
$14.5B
+12.0%
EPS (TTM)
$5.72
P/E Ratio
18.0
Dividend Yield
2.8%
52-Week Range
$99-$134
Beta
0.42
Dimension Scores
Fundamental
75
Technical
65
Sentiment
72
Risk / Reward
76
Momentum
62
FundTechSentRiskMome
Financial Health
Profitability
80strong
Growth
65moderate
Liquidity
84strong
Solvency
77strong
Efficiency
73strong

Valuation, technical analysis, investment thesis, risk assessment and more for $MRK

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.